Simlukafusp Alfa

Simlukafusp Alfa Uses, Dosage, Side Effects, Food Interaction and all others data.

Simlukafusp Alfa is under investigation in clinical trial NCT03193190 (A Study of Multiple Immunotherapy-based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-pancreatic Cancer)).

Trade Name Simlukafusp Alfa
Generic RO6874281
RO6874281 Other Names Anti-fap/interleukin-2 fusion protein ro6874281, Simlukafusp alfa
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Simlukafusp Alfa
Simlukafusp Alfa

Innovators Monograph

You find simplified version here Simlukafusp Alfa


*** Taking medicines without doctor's advice can cause long-term problems.
Share